BACK TO ALL STUDIES

SARS-CoV-2 Neutralizing Assay Concordance Survey (CS)

PRIMARY OBJECTIVE(s)

To conduct a pilot study to evaluate the performance and concordance of SARS-CoV-2 neutralization assays, Angiotensin-converting enzyme 2 (ACE2) Inhibition, and Binding Assays that are developed for diagnostic testing or as a clinical end-point assay for evaluating vaccines or therapeutics.

PRINCIPAL INVESTIGATOR(S)

Thomas Denny, MSc, PHil

CONTACT
Thomas Denny, MSc,PHil
thomas.denny@duke.edu
TREATMENT/CLINICAL & LAB INVESTIGATION

Lab investigation

POPULATION
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test
Lab Used for Serology/Antibody Test
Want more information about this study?
study website